Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pharmacogenet Genomics ; 31(2): 40-47, 2021 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-33044390

RESUMO

OBJECTIVES: Multiple sclerosis (MS) is a neurodegenerative chronic inflammatory. Mutations in the vitamin D receptor (VDR) gene can substantially affect serum vitamin D levels or alter its functionality, and can consequently increase susceptibility to developing MS. The objective of this study was to evaluate the association between polymorphisms in the VDR gene and risk of MS in a (Spanish) Caucasian population. PATIENTS AND METHODS: We conducted a retrospective case-control study comprising 209 patients with relapsing-remitting multiple sclerosis (RRMS) and 836 controls of Caucasian origin from southern Spain. The ApaI (rs7975232), BsmI (rs1544410), Cdx2 (rs11568820), FokI (rs2228570), and TaqI (rs731236) gene polymorphisms were determined by allelic discrimination real-time PCR using TaqMan probes. RESULTS: The recessive logical regression model, adjusted for age and sex, revealed that the TT genotype for VDR FokI (rs2228570) polymorphism was associated with higher risk of MS (P = 0.0150; OR = 1.82; 95% CI = 1.12-2.94; TT vs. CT + CC). No association between the other polymorphisms and development of MS was found in any of the models analyzed. The haplotype analysis, adjusted for age, smoking, and sex, did not find any statistically significant association between the haplotypes analyzed and risk of MS. CONCLUSIONS: The VDR FokI (rs2228570) polymorphism was significantly associated with developing MS. We found no influence of the ApaI (rs7975232), BsmI (rs1544410), Cdx2 (rs11568820), FokI (rs2228570), and TaqI (rs731236) gene polymorphisms on the risk of developing MS in our patients.


Assuntos
Estudos de Associação Genética , Predisposição Genética para Doença , Esclerose Múltipla/genética , Polimorfismo de Nucleotídeo Único/genética , Receptores de Calcitriol/genética , Adulto , Alelos , Feminino , Genótipo , Haplótipos/genética , Humanos , Masculino , Pessoa de Meia-Idade , Esclerose Múltipla/epidemiologia , Esclerose Múltipla/patologia , Fatores de Risco , Espanha/epidemiologia , População Branca/genética
2.
Eur J Hosp Pharm ; 28(6): 350-352, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-32920533

RESUMO

A 70-year-old man with a history of hypertension was evaluated in our dermatology department due to the appearance of a clinical picture compatible with bullous pemphigoid that was confirmed histologically. The lack of response to topical and systemic immunosuppressive treatment resulted in omalizumab being prescribed in a multidisciplinary committee based on the clinical and analytical findings and the patient's refusal to be treated with rituximab. The evaluation at 3 months showed the absence of blisters on the clinical examination. No associated adverse effects were observed. In the following 3 months the patient was administered medication at home in the absence of an anaphylactic reaction and with prior training by the nursing staff of the Hospital Pharmacy Service. After 6 months the medication was suspended with no relapses for 6 months since the last dose. Omalizumab, an anti-IgE monoclonal drug which has a good safety profile with minimum adverse side effects should be considered when there is a contraindication to the use of intravenous therapies (eg, immunoglobulins, rituximab) or prolonged immunosuppressive treatment (eg, methotrexate, azathioprine).


Assuntos
Omalizumab , Penfigoide Bolhoso , Idoso , Humanos , Imunossupressores/uso terapêutico , Masculino , Omalizumab/uso terapêutico , Penfigoide Bolhoso/induzido quimicamente , Penfigoide Bolhoso/tratamento farmacológico , Rituximab/efeitos adversos , Rituximab/uso terapêutico
3.
J Oncol Pharm Pract ; 26(1): 252-255, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31382863

RESUMO

Immune checkpoint inhibitors have become a target for pharmacological research in lung cancer. Immune-related adverse events (irAEs) such as pneumonitis, colitis, hepatitis and endocrinopathies have been well characterized in immune checkpoint inhibitors, but coronary toxicities, like acute coronary syndrome, are poorly described. Herein, we report a possible acute coronary syndrome as immune-related adverse event in a lung cancer patient.


Assuntos
Síndrome Coronariana Aguda/induzido quimicamente , Antineoplásicos Imunológicos/efeitos adversos , Colite/induzido quimicamente , Neoplasias Pulmonares/tratamento farmacológico , Nivolumabe/efeitos adversos , Idoso , Humanos , Masculino , Recidiva
5.
Sultan Qaboos Univ Med J ; 19(4): e369-e371, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31897322

RESUMO

We report a 50-year-old male patient who presented to the Dermatological Outpatient Clinic at the Hospital Universitario San Cecilio, Granada, Spain, in 2017 with symmetrical inguinal eruption and eruption on the dorsum of both feet four hours after the intake of amoxicillin. Physical examination showed confluent non-palpable purpuric macules covering the dorsum of both feet and medial malleolus, giving rise to dusky erythema in some areas. Only oral antihistamines were prescribed and cutaneous exanthema resolved within three weeks. Symmetric drug-related intertriginous and flexural exanthema (SDRIFE) is a sub-type of systemic allergic contact dermatitis, where previous sensitisation can only be demonstrated in up to 50% of patients by skin patch testing. Therefore, a provocation test was performed with amoxicillin without prior skin patch testing. As drug provocation produced the same reaction, the patient was diagnosed with SDRIFE. A parvovirus B19 infection was ruled out by negative serology. SDRIFE is challenging to distinguish from other skin rashes with similar features and distribution; it is important to be aware of these characteristics and their possible causes.


Assuntos
Amoxicilina/efeitos adversos , Antibacterianos/efeitos adversos , Exantema/induzido quimicamente , Dermatoses do Pé/induzido quimicamente , Antagonistas dos Receptores Histamínicos/uso terapêutico , Amoxicilina/administração & dosagem , Antibacterianos/administração & dosagem , Toxidermias , Exantema/tratamento farmacológico , Exantema/patologia , Dermatoses do Pé/tratamento farmacológico , Dermatoses do Pé/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
7.
Cancer Treat Rev ; 37(2): 105-10, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20655664

RESUMO

Taxanes offer clear benefits in adjuvant chemotherapy for early breast cancer. This review examines evidence to date on the clinical effectiveness and cost-effectiveness of their use in the adjuvant treatment of women with early breast cancer, based on three meta-analyses, one systematic review, five clinical practice guidelines and 16 randomized clinical trials. Against the background of a major increase in the use of docetaxel rather than paclitaxel in our setting over the past few years, implying a major increase in costs, we examined whether this higher use of docetaxel is supported by the available evidence. In this wide study, we found no evidence that regimens containing docetaxel yield greater benefits than those including paclitaxel. From an effectiveness standpoint, the change from paclitaxel to docetaxel in our setting is not justified.


Assuntos
Neoplasias da Mama/tratamento farmacológico , Taxoides/uso terapêutico , Neoplasias da Mama/mortalidade , Quimioterapia Adjuvante , Análise Custo-Benefício , Intervalo Livre de Doença , Docetaxel , Feminino , Humanos , Paclitaxel/uso terapêutico , Guias de Prática Clínica como Assunto
8.
J Clin Med Res ; 2(6): 281-3, 2010 Dec 11.
Artigo em Inglês | MEDLINE | ID: mdl-22043263

RESUMO

UNLABELLED: Testicular epidermoid cyst is extremely rare injury, which in recent studies has been regarded as a tumor. Some authors consider this lesion as a cystic monodermal teratoma, the histogenesis remains controversial. In this study we provide clinical and morphological characteristics of an epidermoid cyst in the left testicle in a 16 years old patient, where apparently a nodular lesion in the left testicle was detected. KEYWORDS: Cyst; Epidermoid; Intratesticular.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...